Get started
Author

Daichi Hino

Observed name: DAICHI HINO
ORCID: 0000-0002-9045-7623
Observed ORCID: 0000-0002-9045-7623
OpenAlex ID: A5036806281
Patients’ poor performance status is an independent risk factor for urosepsis induced by kidney and ureteral stones
2021 · Mika Kino, Takumi Hayashi, et al. · Urolithiasis · 12
Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study
2025 · Yosuke Kinoshita, Yasutaka Yamada, et al. · Japanese Journal of Clinical Oncology · 6
Successful radiofrequency ablation of liver metastases from prostate cancer
2022 · Daichi Hino, Takahiro Sugano, et al. · IJU Case Reports · 3
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis
2025 · Tomoki Shirafuji, Yasutaka Yamada, et al. · British Journal of Urology · 2
Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer
2026 · YASUTAKA YAMADA, MARIKA MATSUMOTO, et al. · Anticancer Research · 1
A Two‐Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone‐Sensitive Prostate Cancer
2026 · Koichiro Kurokawa, Satoshi Yamamoto, et al. · The Prostate · 1
Prognostic impact of primary Gleason pattern 5 in patients with low-volume metastatic hormone-sensitive prostate cancer treated with upfront ARPI-based doublet therapy: a real-world multicenter international collaborative study
2026 · Yasutaka Yamada, Kodai Sato, et al. · International Journal of Clinical Oncology
Impact of Age on Treatment Patterns and Outcomes in Patients With Non‐Metastatic Castration‐Resistant Prostate Cancer
2025 · Hiroki Hagimoto, Shinichi Sakamoto, et al. · International Journal of Urology
Works count: 8
Citation count: 25
H-index: 3
I10-index: 1
Year
Topic
Type